Literature DB >> 19215250

Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.

R Sharman1, K Sullivan, R Young, J McGill.   

Abstract

Debate continues as to why executive function (EF) continues to show impairments in children with early and continuously treated phenylketonuria (ECT-PKU). Using a mixed model, we measured EF in 10 adolescent children with ECT-PKU and 6 sibling controls, and examined associations between EF and (1) phenylalanine (phe) and (2) the phenylalanine : tyrosine ratio (phe : tyr). Measurements were taken on two occasions anticipated to yield variation in concurrent biochemistry resulting from changes in dietary compliance (i.e. holiday vs non-holiday period). A repeated measures anova using the Behaviour Rating Inventory of Executive Function yielded the following results: no significant interactions; two significant group effects of substantially impaired working memory and initiation skills in children with ECT-PKU compared with controls, irrespective of occasion and two significant time effects, suggestive of slightly poorer non-holiday planning and organization scores in both groups. Further analyses revealed that phe levels were not significantly different on these occasions, suggesting that holiday dietary compliance may be better than expected. Correlations between EF and biochemistry in children with PKU showed that participant's lifetime phe : tyr ratio was positively and significantly associated with EF impairment, more so than phe-only measures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215250     DOI: 10.1111/j.1399-0004.2008.01101.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  Up to date knowledge on different treatment strategies for phenylketonuria.

Authors:  Amaya Bélanger-Quintana; Alberto Burlina; Cary O Harding; Ania C Muntau
Journal:  Mol Genet Metab       Date:  2011-08-16       Impact factor: 4.797

2.  Tyrosine monitoring in children with early and continuously treated phenylketonuria: results of an international practice survey.

Authors:  Rachael Sharman; Karen A Sullivan; Ross McD Young; James J McGill
Journal:  J Inherit Metab Dis       Date:  2010-09-30       Impact factor: 4.982

Review 3.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

4.  Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride.

Authors:  Teresa D Douglas; Usha Ramakrishnan; Julie A Kable; Rani H Singh
Journal:  Health Qual Life Outcomes       Date:  2013-12-30       Impact factor: 3.186

5.  Effects of maternal worm infections and anthelminthic treatment during pregnancy on infant motor and neurocognitive functioning.

Authors:  Margaret Nampijja; Barbara Apule; Swaib Lule; Hellen Akurut; Lawrence Muhangi; Emily L Webb; Charlie Lewis; Alison M Elliott; Katie J Alcock
Journal:  J Int Neuropsychol Soc       Date:  2012-11       Impact factor: 2.892

6.  Executive function in adolescents with PKU and their siblings: Associations with biochemistry.

Authors:  R Sharman; K Sullivan; R Young; J McGill
Journal:  Mol Genet Metab Rep       Date:  2015-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.